首页> 外文期刊>Nature >Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
【24h】

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

机译:与TSA和SAHA抑制剂结合的组蛋白脱乙酰基酶同系物的结构

获取原文
获取原文并翻译 | 示例
           

摘要

Histone deacetyiases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeo-licus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as anti-tumour agents.
机译:组蛋白脱乙酰基酶(HDAC)介导核小体构象的变化,在调节基因表达中很重要。 HDAC与细胞周期进程和分化有关,其失调与几种癌症有关。 HDAC抑制剂,例如曲古抑菌素A(TSA)和辛二酰苯胺基异羟肟酸(SAHA),具有抗肿瘤作用,因为它们可以抑制细胞生长,诱导终末分化并防止小鼠模型中肿瘤的形成,并且它们在小鼠模型中是有效的。治疗早幼粒细胞白血病。在这里,我们描述了组蛋白脱乙酰基酶催化核心的结构,正如超嗜热细菌Aquifex aeo-licus的同系物的晶体结构所揭示的那样,该蛋白与人HDAC1共有35.2%的同一性,超过375个残基,在体外使组蛋白脱乙酰基并受到抑制TSA和SAHA。脱乙酰基酶,脱乙酰基酶-TSA和脱乙酰基酶-SAHA结构揭示了一个活性位点,该活性位点由一个管状袋,一个锌结合位点和两个Asp-His电荷中继系统组成,并建立了HDAC抑制机制。组成活性位点并与抑制剂接触的残基在整个HDAC系列中都是保守的。这些结构还暗示了脱乙酰基反应的机制,并为进一步开发HDAC抑制剂作为抗肿瘤剂提供了框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号